• August 25, 2020

Lonza Pharma & Biotech provides integrated DPI (dry powder inhaler) development services to advance molecules, drawing on 25 years of experience in particle engineering, formulation design, and encapsulation techniques. Our premier particle engineering technologies services, utilizing both jet milling and spray drying, are tailored to your molecule, target product profile and delivery device. Dedicated DPI […]

  • March 5, 2018

Catalent offers flexible manufacturing solutions at scales suitable to reliably supply pre-clinical evalutation studies through to clinical studies and into the marketplace. Our inhalation manufacturing operations have a track record of regulatory excellence, and we routinely manufacture pMDIs, DPIs, and nasal formulations for clients around the globe.